Retraction: Inhibition of Bcl2L12 attenuates eosinophilia-related inflammation in heart
- 1State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- 2Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China
- 3Department of Otolaryngology, First Affiliated Hospital of Shenzhen University, Shenzhen, China
- 4Department of Otolaryngology, Longgang Central Hospital, Shenzhen, China
- 5Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China
Citation: Chen X, Zhao M-Z, Miao B-P, Liu Z-Q, Yang G, Liu J-Q, Yang P-C and Song J-P (2020) Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart. Front. Immunol. 11:1955. doi: 10.3389/fimmu.2020.01955
Received: 05 March 2020; Accepted: 20 July 2020;
Published: 11 September 2020; Retracted: 05 June 2023.
Edited by:
Guochang Hu, University of Illinois at Chicago, United StatesReviewed by:
VijayaKumar Sukumaran, Qatar University, QatarGabriela Kania, University Hospital Zürich, Switzerland
Chandirasegaran Massilamany, CRISPR Therapeutics, Inc., United States